TY - JOUR
T1 - A twenty-year experience with adenocarcinoma of the anal canal
AU - Chang, George J.
AU - Gonzalez, Ricardo J.
AU - Skibber, John M.
AU - Eng, Cathy
AU - Das, Prajnan
AU - Rodriguez-Bigas, Miguel A.
N1 - Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2009/8
Y1 - 2009/8
N2 - PURPOSE: Adenocarcinoma of the anal canal is a rare malignancy with limited data regarding treatment and outcomes. The purpose of this study is to evaluate disease control and survival outcomes in patients with adenocarcinoma of the anal canal. METHODS: A retrospective consecutive cohort study of all patients in whom adenocarcinoma of the anal canal was diagnosed between 1983 and 2004 was performed. Tumor, patient, and treatment characteristics were categorized. Overall survival and recurrence outcomes were evaluated by use of the Kaplan-Meier method and the log-rank test. Cox proportional hazards regression analysis was performed to evaluate covariate adjusted effects. RESULTS: Thirty-four patients were identified; six underwent palliative treatment (Stage IV, n = 4; poor performance, n = 2). Median follow-up for the remaining 28 patients was 37 months (interquartile range, 22-62 months). Thirteen patients (46%) were treated with local excision followed by radiotherapy or chemoradiotherapy. Fifteen patients (54%) underwent radical surgery and preoperative or postoperative chemoradiotherapy. Median disease-free survival was 13 months after local excision and 32 months after radical surgery (P = 0.055). Overall survival at five years was 43% for patients treated with local excision and 63% for patients treated with radical surgery (P = 0.3). Tumor grade was predictive of overall survival (P = 0.04) and recurrence (P = 0.046). On multivariate analysis, the type of surgical treatment was an important predictor of overall survival (P = 0.045) and disease-free survival (P = 0.004). CONCLUSION: Combined modality treatment with radical surgical resection improves survival among patients with adenocarcinoma of the anal canal, but a high risk for distant failure emphasizes the need for effective adjuvant therapeutic regimens.
AB - PURPOSE: Adenocarcinoma of the anal canal is a rare malignancy with limited data regarding treatment and outcomes. The purpose of this study is to evaluate disease control and survival outcomes in patients with adenocarcinoma of the anal canal. METHODS: A retrospective consecutive cohort study of all patients in whom adenocarcinoma of the anal canal was diagnosed between 1983 and 2004 was performed. Tumor, patient, and treatment characteristics were categorized. Overall survival and recurrence outcomes were evaluated by use of the Kaplan-Meier method and the log-rank test. Cox proportional hazards regression analysis was performed to evaluate covariate adjusted effects. RESULTS: Thirty-four patients were identified; six underwent palliative treatment (Stage IV, n = 4; poor performance, n = 2). Median follow-up for the remaining 28 patients was 37 months (interquartile range, 22-62 months). Thirteen patients (46%) were treated with local excision followed by radiotherapy or chemoradiotherapy. Fifteen patients (54%) underwent radical surgery and preoperative or postoperative chemoradiotherapy. Median disease-free survival was 13 months after local excision and 32 months after radical surgery (P = 0.055). Overall survival at five years was 43% for patients treated with local excision and 63% for patients treated with radical surgery (P = 0.3). Tumor grade was predictive of overall survival (P = 0.04) and recurrence (P = 0.046). On multivariate analysis, the type of surgical treatment was an important predictor of overall survival (P = 0.045) and disease-free survival (P = 0.004). CONCLUSION: Combined modality treatment with radical surgical resection improves survival among patients with adenocarcinoma of the anal canal, but a high risk for distant failure emphasizes the need for effective adjuvant therapeutic regimens.
KW - Anal adenocarcinoma
KW - Multimodality therapy
UR - http://www.scopus.com/inward/record.url?scp=68149158989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68149158989&partnerID=8YFLogxK
U2 - 10.1007/DCR.0b013e3181a79589
DO - 10.1007/DCR.0b013e3181a79589
M3 - Article
C2 - 19617747
AN - SCOPUS:68149158989
SN - 0012-3706
VL - 52
SP - 1375
EP - 1380
JO - Diseases of the colon and rectum
JF - Diseases of the colon and rectum
IS - 8
ER -